Jigar Choksey - 09 Jun 2022 Form 4/A - Amendment Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role
Director
Signature
/s/ Christopher Krueger, as Attorney-in-Fact
Issuer symbol
VTYX
Transactions as of
09 Jun 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
01 Jul 2022, 16:23:05 UTC
Date Of Original Report
10 Jun 2022
Previous filing
20 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VTYX Stock Option (right to buy) 0 09 Jun 2022 Common Stock 0 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Form 4 filed on June 10, 2022, erroneously reported that Mr. Choksey received an annual option award under the Company's Outside Director Compensation Policy on June 9, 2022. However, Mr. Choksey had previously waived his right to receive such award and such award did not occur.